Hemolytic-uremic syndrome: Difference between revisions

	Hemolytic-uremic syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemolytic-uremic syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemolytic-uremic syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemolytic-uremic syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemolytic-uremic syndrome
CDC on Hemolytic-uremic syndrome
Hemolytic-uremic syndrome in the news
Blogs on Hemolytic-uremic syndrome
Directions to Hospitals Treating Hemolytic-uremic syndrome
Risk calculators and risk factors for Hemolytic-uremic syndrome

Revision as of 20:24, 16 August 2018

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2] Synonyms and keywords:

@@ Line 1: / Line 1: @@
 __NOTOC__
 '''For patient information click [[Hemolytic-uremic syndrome (patient information)|here]]'''
 {{Infobox_Disease |
@@ Line 21: / Line 22: @@
 ==[[Hemolytic-uremic syndrome classification|Classification]]==
 ==[[Hemolytic-uremic syndrome pathophysiology |Pathophysiology]]==
-* Shiga toxin-induced
-endothelial cytotoxicity in the hemolytic uremic syndrome after infection
-with Shiga toxin–producing Escherichia coli or other microorganisms.
-Thrombotic microangiopathy can also occur in patients with
-pneumococcal sepsis and less commonly other infections in which
-microbial neuraminidases expose the Thomsen-Friedenreich
-antigen on endothelial and red cells, subjecting the cells to attack
-by preexisting antibodies against the antigen
 ==[[Hemolytic-uremic syndrome causes|Causes]]==
 ==[[Hemolytic-uremic syndrome differential diagnosis|Differentiating Hemolytic-uremic syndrome from other Diseases]]==
-==[[Hemolytic-uremic syndrome epidemiology and demographics|Epidemiology and Demographics]]==
+==[[Hemolytic-uremic syndrome epidemiology and demographics|Epidemiology and Demographics]].==
-Hemolytic uremic syndrome occurs one to three cases per 100,000 children  in children one to 10 years of age annually.
 ==[[Hemolytic-uremic syndrome screening|Screening]]==
 ==[[Hemolytic-uremic syndrome natural history, complications and prognosis|Natural History, Complications and Prognosis]]==